Tactical Therapeutics Overview
- Year Founded
-
2005
- Status
-
Private
- Latest Deal Type
-
Series B
- (In Progress)
- Latest Deal Amount
-
$35M
Tactical Therapeutics General Information
Description
Developer of a clinical-stage therapeutic drug intended to demonstrate safety and efficacy in primary brain cancer glioblastoma. The company's drugs include therapeutic orotate for the orphan indication glioblastoma and for other refractory targets and its products modulate multiple signaling pathways and work in combination with traditional chemotherapy and targeted drugs to achieve clinical efficacy, help physicians to overcome resistance in malignant brain cancer and for resistance and recurrence of tumors and
Contact Information
Website
www.tacticaltherapeutics.comCorporate Office
- 48 Wall Street
- 12th Floor
- New York, NY 10005
- United States
Corporate Office
- 48 Wall Street
- 12th Floor
- New York, NY 10005
- United States
Tactical Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 09-Jan-2024 | $35M | In Progress | Clinical Trials - Phase 2 | ||
| 4. Later Stage VC (Series 1) | In Progress | Clinical Trials - Phase 2 | ||||
| 3. Later Stage VC (Series A) | 08-Jan-2024 | In Progress | Clinical Trials - Phase 2 | |||
| 2. Later Stage VC (Series A) | 03-Sep-2021 | $50M | Cancelled | Clinical Trials - Phase 2 | ||
| 1. Angel (individual) | $20M | $20M | Completed | Startup |
Tactical Therapeutics Comparisons
Industry
Financing
Details
Tactical Therapeutics Competitors (1)
One of Tactical Therapeutics’s competitors is MimiVax, a Venture Capital-Backed company based in Buffalo, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MimiVax | Venture Capital-Backed | Buffalo, NY |
Tactical Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tactical Therapeutics Patents
Tactical Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11318118-B1 | Methods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate | Active | 05-Apr-2021 | ||
| AU-2021322599-A1 | Methods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate | Pending | 05-Aug-2020 | ||
| CA-3185943-A1 | Methods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate | Active | 05-Aug-2020 | ||
| EP-4192452-A1 | Methods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate | Pending | 05-Aug-2020 | ||
| CA-3185943-C | Methods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate | Active | 05-Aug-2020 | A61P31/12 |
Tactical Therapeutics FAQs
-
When was Tactical Therapeutics founded?
Tactical Therapeutics was founded in 2005.
-
Where is Tactical Therapeutics headquartered?
Tactical Therapeutics is headquartered in New York, NY.
-
What industry is Tactical Therapeutics in?
Tactical Therapeutics’s primary industry is Drug Discovery.
-
Is Tactical Therapeutics a private or public company?
Tactical Therapeutics is a Private company.
-
What is Tactical Therapeutics’s current revenue?
The current revenue for Tactical Therapeutics is .
-
How much funding has Tactical Therapeutics raised over time?
Tactical Therapeutics has raised $35M.
-
Who are Tactical Therapeutics’s competitors?
MimiVax is a competitor of Tactical Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
